Elevance Health (ELV) Total Non-Current Liabilities (2009 - 2026)
Elevance Health (ELV) posted quarterly Total Non-Current Liabilities of $77.1 billion for Q2 2026, up 3.97% year-over-year from $74.2 billion in Q2 2025, and down 0.94% quarter-over-quarter from $77.9 billion in Q1 2026.
Elevance Health (ELV) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Elevance Health (ELV) has reported Total Non-Current Liabilities for 18 consecutive years, with $77.1 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Non-Current Liabilities rose 3.97% year-over-year to $77.1 billion; the TTM figure through Jun 2026 stood at $77.1 billion (up 3.97% YoY), while the FY2025 annual figure was $73.9 billion, up 2.5% from the prior year.
- Total Non-Current Liabilities retreated to $77.1 billion in Q2 2026 per ELV's latest filing, from $77.9 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $77.9 billion in Q1 2026 and bottomed at -$1.5 billion in Q4 2022.
- Historically, Total Non-Current Liabilities has averaged $66.5 billion across 5 years, with a median of $69.6 billion in 2023.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities surged 4574.26% — and 2024, when it decreased 1.3%.
- Elevance Health's Total Non-Current Liabilities stood at -$1.5 billion in 2022, then soared by 4574.26% to $67.8 billion in 2023, then climbed by 6.42% to $72.1 billion in 2024, then increased by 2.5% to $73.9 billion in 2025, then climbed by 4.31% to $77.1 billion in 2026.
- Business Quant data shows ELV's Total Non-Current Liabilities at $77.1 billion in Q2 2026, $77.9 billion in Q1 2026, and $73.9 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Unitedhealth | 351.82 Bn | 320.35 Bn | 36.67 Bn | 184.04 Bn |
| 2 | Cvs Health | 119.07 Bn | 105.11 Bn | 47.23 Bn | 167.76 Bn |
| 3 | Elevance Health | 87.07 Bn | 51.12 Bn | 13.45 Bn | 77.13 Bn |
| 4 | Humana | 45.80 Bn | 21.93 Bn | 5.50 Bn | 34.99 Bn |
| 5 | Centene | 31.92 Bn | 4.86 Bn | 14.55 Bn | 57.55 Bn |
| 6 | Molina Healthcare | 10.31 Bn | 1.39 Bn | 1.43 Bn | 11.65 Bn |
| 7 | Oscar Health | 9.45 Bn | 890.37 Mn | 1.09 Bn | 9.12 Bn |
| 8 | Alignment Healthcare | 2.72 Bn | 2.01 Bn | 180.96 Mn | - |
| 9 | Clover Health Investments | 2.15 Bn | 1.91 Bn | 153.00 Mn | 323.33 Mn |
| 10 | Progyny | 2.00 Bn | 1.76 Bn | 89.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.13 Bn |
| Mar 31, 2026 | 77.86 Bn |
| Dec 31, 2025 | 73.94 Bn |
| Sep 30, 2025 | 74.53 Bn |
| Jun 30, 2025 | 74.18 Bn |
| Mar 31, 2025 | 73.10 Bn |
| Dec 31, 2024 | 72.14 Bn |
| Sep 30, 2024 | 69.06 Bn |
| Jun 30, 2024 | 68.71 Bn |
| Mar 31, 2024 | 69.28 Bn |
| Dec 31, 2023 | 67.79 Bn |
| Sep 30, 2023 | 69.97 Bn |
| Jun 30, 2023 | 69.08 Bn |
| Mar 31, 2023 | 69.93 Bn |
| Dec 31, 2022 | -1.52 Bn |
| Sep 30, 2022 | 65.20 Bn |
| Jun 30, 2022 | 63.32 Bn |
| Mar 31, 2022 | 62.78 Bn |
| Dec 31, 2021 | -1.72 Bn |
| Sep 30, 2021 | 60.34 Bn |